Skip to main navigation Skip to search Skip to main content

Detection of Anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery

  • Joonho Lee
  • , Roberto Romero
  • , Yi Xu
  • , Jezid Miranda
  • , Wonsuk Yoo
  • , Piya Chaemsaithong
  • , Juan Pedro Kusanovic
  • , Tinnakorn Chaiworapongsa
  • , Adi L. Tarca
  • , Steven J. Korzeniewski
  • , Sonia S. Hassan
  • , Nandor Gabor Than
  • , Bo Hyun Yoon
  • , Chong Jai Kim
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Wayne State University School of Medicine
  • University of Tennessee Health Science Center
  • Pontificia Universidad Católica de Chile
  • Sótero del Río Hospital
  • Wayne State University College of Engineering
  • Seoul National University College of Medicine
  • University of Ulsan College of Medicine

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Abstract

Problem: Maternal anti-fetal rejection is a mechanism of disease in spontaneous preterm labor. The objective of this study was to determine whether the presence of human leukocyte antigen (HLA) panel-reactive antibodies (PRA) during the second trimester increases the risk of spontaneous preterm delivery. Methods of study: This longitudinal case-control study included pregnant women with spontaneous preterm deliveries (n = 310) and control patients with normal term pregnancies (n = 620), matched for maternal age and gravidity. Maternal plasma samples obtained at 14-16, 16-20, 20-24, and 24-28 weeks of gestation were analyzed for HLA class I and class II PRA positivity using flow cytometry. The fetal HLA genotype and maternal HLA alloantibody epitope were determined for a subset of patients with positive HLA PRA. Results: (i) Patients with spontaneous preterm delivery were more likely to exhibit HLA class I (adjusted OR = 2.54, P < 0.0001) and class II (adjusted OR = 1.98, P = 0.002) PRA positivity than those delivering at term; (ii) HLA class I PRA positivity for patients with spontaneous preterm delivery between 28 and 34 weeks (adjusted OR = 2.88; P = 0.001) and after 34 weeks of gestation (adjusted OR = 2.53; P < 0.0001) was higher than for those delivering at term; (iii) HLA class II PRA positivity for patients with spontaneous preterm delivery after 34 weeks of gestation was higher than for those delivering at term (adjusted OR = 2.04; P = 0.002); (iv) multiparous women were at a higher risk for HLA class I PRA positivity than nulliparous women (adjusted OR = 0.097, P < 0.0001 for nulliparity); (v) nulliparous women had a higher rate of HLA class I PRA positivity with advancing gestational age (P = 0.001); and (vi) 78% of women whose fetuses were genotyped had alloantibodies specific against fetal HLA class I antigens. Conclusion: Pregnant women with positive HLA class I or class II PRA during the second trimester are at an increased risk of spontaneous preterm delivery due to antibody-mediated maternal anti-fetal rejection.

Original languageEnglish
Pages (from-to)162-175
Number of pages14
JournalAmerican Journal of Reproductive Immunology
Volume70
Issue number2
DOIs
Publication statusPublished - Aug 2013
Externally publishedYes

Keywords

  • Flow cytometry
  • Preterm birth
  • Rejection
  • Transplantation

Fingerprint

Dive into the research topics of 'Detection of Anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery'. Together they form a unique fingerprint.

Cite this